Evidence map›Paper›PMID 40932599›Full record

ArticleMolecular biology reports2025

Prevalence of human papillomavirus (HPV) genotypes among outpatients referred to five laboratories in Shiraz, Iran.

Mohammadreza Heydari, Sina Bazmi, Zahra Mohammadi, Babak Shirazi Yeganeh, Saeid Amirizadeh Fard, Esmaeil Rezaei, Gholamhossein Keighobadi, Mojgan Akbarzadeh Jahromi, Mozhgan Karimi, Ahmad Monabati and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohammadreza HeydariHIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID http://orcid.org/0000-0003-4124-6085
Sina BazmiUSERN Office, Fasa University of Medical Sciences, Fasa, Iran.ORCID http://orcid.org/0000-0002-2128-0924
Zahra MohammadiStudent Research Committee , Fasa University of Medical Sciences , Fasa, Iran.
Babak Shirazi YeganehPathology Department, Shiraz Medical School, Shiraz, Iran.
Saeid Amirizadeh FardGastroenterohepatology Research Center , Shiraz University of medical Sciences , Shiraz, Iran.ORCID http://orcid.org/0000-0003-2347-5204
Esmaeil RezaeiDepartment of Biochemistry, Faculty of Biological Sciences , Tarbiat Modares University , Tehran, Iran.
Gholamhossein KeighobadiDepartment of Agricultural Management, Shiraz Branch , Islamic Azad University , Shiraz, Iran.
Mojgan Akbarzadeh JahromiDepartment of Pathology, School of Medicine, Maternal-fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID http://orcid.org/0000-0003-0874-3127
Mozhgan KarimiPeyvand Pathobiology and Genetic Laboratory, Shiraz, Iran.
Ahmad MonabatiDepartment of Pathology, School of Medicine, Maternal-fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID http://orcid.org/0000-0002-3378-1937
Maryam NejabatGastroenterohepatology Research Center , Shiraz University of medical Sciences , Shiraz, Iran. maryamnejabat@gmail.com.ORCID http://orcid.org/0000-0002-6818-2563

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHuman papillomavirus (HPV) is the most common sexually transmitted infection and a major cause of genital warts and anogenital cancers in both sexes. This study assessed HPV genotype distribution in a large outpatient population in southwestern Iran to inform preventive strategies. MATERIALS AND

methodsIn this cross-sectional study, 10,739 outpatient samples were collected from 2018 to 2023. Specimens included urine from men and vaginal swabs from women with normal cytology. HPV genotypes were assessed using DNA extraction, PCR and Direct Flow Chip method.

resultsHPV prevalence was 41.6% (94.8% in females, 5.2% in males). Women had a higher positivity rate (42.0%) than men (34.2%). The highest prevalence (44.3%) occurred in the 31-40 age group. High-risk types were present in 65.8% of positive cases. Women were more affected by high-risk genotypes, while low-risk types predominated in men. The most frequent high-risk genotypes were HPV-16, -53, -52, -66, and - 39; the most common low-risk types were HPV-6, -54, -42, -62, and - 44. Most individuals had a single infection. Mixed infections, more common in women, often involved both high- and low-risk types and showed greater diversity with age.

conclusionHPV prevalence, particularly of high-risk types, is notably high among women in southwestern Iran. The peak age of infection is higher than in developed countries. Differences in genotype distribution compared to American and other Iranian studies highlight the need for region-specific vaccination strategies targeting locally prevalent genotypes.

Indexed as

PapillomaviridaePapillomavirus InfectionsAdolescentAdultAgedChildCross-Sectional StudiesFemaleGenotypeHuman Papillomavirus VirusesHumansIranMaleMiddle AgedOutpatientsPrevalenceEpidemiologyGenotypeHuman papillomavirusIranPolymerase chain reactionPrevalenceVaccination

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.